Join to view full profile
759 Chestnut StreetSpringfield, MA 01199
Phone+1 413-794-7394
Fax+1 413-794-7136
Dr. Schimmel is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterFellowship, Infectious Disease, 2005 - 2009
University of Vermont Medical CenterResidency, Internal Medicine, 2001 - 2004
Uconn School Of MedicineClass of 2001
Certifications & Licensure
MA State Medical License 2007 - 2027
NY State Medical License 2004 - 2006
VT State Medical License 2001 - 2006
PA State Medical License 2003 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 2 citationsDalbavancin Use in Persons Who Use Drugs May Increase Adherence Without Increasing Cost.Tiffany A Russo, Hannah R Ritchie, Jennifer J Schimmel, Michael P Lorenzo
The Journal of Pharmacy Technology. 2024-02-01 - 11 citationsClinical failure of dalbavancin for MRSA bacteremia in patient with severe obesity and history of IVDU.Hannah Ritchie, Abhimanyu Aggarwal, Jennifer Schimmel, Michael P Lorenzo
Journal of Infection and Chemotherapy. 2022-03-01 - 12 citationsPneumococcal Urinary Antigen Testing in United States Hospitals: A Missed Opportunity for Antimicrobial Stewardship.Jennifer J Schimmel, Sarah Haessler, Peter B. Imrey, Peter K. Lindenauer, Sandra S. Richter
Clinical Infectious Diseases. 2020-09-12
Press Mentions
Practice ManagementOctober 17th, 2019
Grant Support
- Identifying environmental pollutants detrimental to the cardiovascular systemBOSTON UNIVERSITY MEDICAL CAMPUS2025–2028
- Optimizing a human relevant mouse model to study adverse health effects of PFASBOSTON UNIVERSITY MEDICAL CAMPUS2024–2026
- Optimizing a human relevant mouse model to study adverse health effects of PFASBOSTON UNIVERSITY MEDICAL CAMPUS2024–2026
- Investigating the Perturbation of Bone Health by Per/Polyfluoroalkyl SubstancesBOSTON UNIVERSITY MEDICAL CAMPUS2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
